Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun:192:106783.
doi: 10.1016/j.phrs.2023.106783. Epub 2023 May 8.

Unanswered questions in the regulation and function of the duplicated α7 nicotinic receptor gene CHRFAM7A

Sherry Leonard  1 , Roberta Benfante  2
Affiliations
Free article
Review

Unanswered questions in the regulation and function of the duplicated α7 nicotinic receptor gene CHRFAM7A

Sherry Leonard et al. Pharmacol Res. 2023 Jun.
Free article

Abstract

The α7 nicotinic receptor (α7 nAChR) is an important entry point for Ca2+ into the cell, which has broad and important effects on gene expression and function. The gene (CHRNA7), mapping to chromosome (15q14), has been genetically linked to a large number of diseases, many of which involve defects in cognition. While numerous mutations in CHRNA7 are associated with mental illness and inflammation, an important control point may be the function of a recently discovered partial duplication CHRNA7, CHRFAM7A, that negatively regulates the function of the α7 receptor, through the formation of heteropentamers; other functions cannot be excluded. The deregulation of this human specific gene (CHRFAM7A) has been linked to neurodevelopmental, neurodegenerative, and inflammatory disorders and has important copy number variations. Much effort is being made to understand its function and regulation both in healthy and pathological conditions. However, many questions remain to be answered regarding its functional role, its regulation, and its role in the etiogenesis of neurological and inflammatory disorders. Missing knowledge on the pharmacology of the heteroreceptor has limited the discovery of new molecules capable of modulating its activity. Here we review the state of the art on the role of CHRFAM7A, highlighting unanswered questions to be addressed. A possible therapeutic approach based on genome editing protocols is also discussed.

Keywords: CHRFAM7A; CHRNA7; CRISPR/dCas9; Drug development; Human-specific gene; Nicotinic receptor.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Human restricted CHRFAM7A gene increases brain efficiency.
    Jakimovski D, Dorn RP, Regno MD, Bartnik A, Bergsland N, Ramanathan M, Dwyer MG, Benedict RHB, Zivadinov R, Szigeti K. Jakimovski D, et al. Front Neurosci. 2024 Apr 22;18:1359028. doi: 10.3389/fnins.2024.1359028. eCollection 2024. Front Neurosci. 2024. PMID: 38711941 Free PMC article.

Substances